Ryan David Lake, Chief Financial Officer at Recro Pharma, Inc. (REPH), bought 1,212 shares at $1.62 ($2K) on 2021-11-12, disclosed to the SEC on 2021-11-16.
Open-market purchase of $2k REPH by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.62 | 50 | $81 | 4.1% |
| 2 | $1.65 | 1,162 | $2K | 95.9% |
| Total | $1.65 avg | 1,212 | $2K | 100% |